Accenture plc filings document the regulatory record of a global professional services company, including operating results, material events, governance matters and capital-structure disclosures. The company’s 8-K reports cover quarterly and annual financial results, non-GAAP measures such as free cash flow and local-currency revenue and bookings, and material financing arrangements including senior unsecured revolving credit facilities used for general corporate purposes and to support its commercial paper program.
Proxy materials describe shareholder voting matters, board and executive compensation disclosures, equity award information and governance practices. Other filings record leadership and organizational changes, including Accenture’s integrated Reinvention Services business unit, as well as risk, liquidity and financial reporting topics relevant to its consulting, technology and operations services model.
Accenture plc (ACN) director Jaime Ardila reported a grant of 5 Class A ordinary shares in the form of restricted share units on 11/14/2025. The filing explains that these RSUs were issued under the anti-dilution provisions of previously granted RSU awards to reflect Accenture’s payment of a cash dividend, meaning they are an adjustment rather than a new incentive grant. The RSUs were acquired at a stated price of $0, and following this transaction Ardila beneficially owns 12,129 Class A ordinary shares, held directly.
Accenture plc director reports small RSU adjustment after dividend
A director of Accenture plc (ACN) reported receiving 7 Class A ordinary shares on 11/14/2025, shown at a price of $0. The filing explains this as a grant of restricted share units (RSUs) under anti-dilution provisions of previously granted RSU awards, made to reflect Accenture’s payment of a cash dividend. Following this adjustment, the director beneficially owns 8,580 Class A ordinary shares held directly.
Accenture plc (ACN) director reports small equity award linked to dividend. On 11/14/2025, a director acquired 5 Class A ordinary shares at a price of $0, increasing their beneficial ownership to 624 shares held directly. The filing explains that this was a grant of restricted share units made under anti-dilution provisions of previously granted RSU awards, intended to reflect Accenture’s payment of a cash dividend. This is a routine adjustment that keeps the director’s prior equity awards economically consistent after the dividend payment.
Accenture plc (ACN) reported a Form 4 for its CEO-The Americas, John F. Walsh, covering equity award adjustments tied to a recent cash dividend. On 11/14/2025, he acquired 93 Class A ordinary shares at $0 per share through a grant of restricted share units (RSUs) made under the anti-dilution provisions of previously granted RSU awards. On the same date, 41 Class A ordinary shares were disposed of at $246.62 per share, reported with transaction code “F,” which typically reflects shares withheld to cover tax obligations. Following these transactions, he beneficially owned 22,422 Class A ordinary shares, held directly.
Accenture plc (ACN) Chair and CEO Julie Spellman Sweet, who also serves as a director, reported changes in her Accenture share holdings. On 11/14/2025, she acquired 333 Class A ordinary shares at $0 per share, increasing her position through a grant of restricted share units (RSUs) made under anti-dilution provisions tied to Accenture’s payment of a cash dividend. On the same date, she had a disposition coded “F” of 148 Class A ordinary shares at $246.62 per share. After these transactions, she beneficially owned 8,941 Class A ordinary shares in direct ownership.
Accenture plc officer Katherine Lee Clifford reported receiving a grant of 32 Class A ordinary shares in the form of restricted share units. The grant occurred on 11/14/2025 at a price of $0 per share, reflecting anti-dilution adjustments to previously granted RSU awards following Accenture plc's payment of a cash dividend.
After this transaction, Clifford beneficially owns 4,919 Class A ordinary shares directly and 27 shares indirectly through an immediate family member. The filing is made on behalf of Clifford by an attorney-in-fact and reflects routine equity compensation adjustments tied to dividend payments rather than an open-market purchase or sale.
Accenture plc officer Ryoji Sekido, Co-CEO Asia Pacific, reported a new equity award in the company’s Class A ordinary shares. On 11/14/2025, he acquired 26 shares at a price of $0, recorded as a grant of restricted share units under existing awards. The filing explains that these RSUs were issued pursuant to anti-dilution provisions to reflect Accenture’s payment of a cash dividend, meaning the award adjusts prior grants so their value is maintained after the dividend. Following this transaction, Sekido beneficially owns 1,416 Accenture Class A ordinary shares in direct form.
Accenture plc (ACN) reported an insider equity transaction by its Chief Executive Officer-EMEA, Mauro Macchi. On 11/14/2025, he received a grant of 26 Class A ordinary shares in the form of restricted share units, issued under anti-dilution provisions to reflect Accenture’s cash dividend. On the same date, 12 Class A ordinary shares were disposed of at $246.62 per share under code “F,” indicating shares withheld, typically for tax obligations. Following these transactions, he directly beneficially owns 4,415 Class A ordinary shares.
Accenture plc director reports small anti-dilution RSU grant
A director of Accenture plc (ACN) reported receiving 5 Class A ordinary shares on 11/14/2025 through a grant of restricted share units. The filing explains that these RSUs were granted under the anti-dilution provisions of previously granted RSU awards to reflect Accenture's payment of a cash dividend, so the director did not pay any purchase price, which is shown as $0 per share. Following this adjustment, the director beneficially owns 3,708 Class A ordinary shares directly.
Accenture plc (ACN) reported that director Arun Sarin received a grant of 5 Class A ordinary shares in the form of restricted share units. The grant was made pursuant to anti-dilution provisions in previously granted RSU awards to reflect Accenture’s payment of a cash dividend, and carried a stated price of $0. Following this adjustment, Sarin beneficially owns 8,478 Class A ordinary shares in the company, held directly. This filing reflects a routine, small equity adjustment rather than a market purchase or sale.